1. Home
  2. BLTE vs ADUS Comparison

BLTE vs ADUS Comparison

Compare BLTE & ADUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • ADUS
  • Stock Information
  • Founded
  • BLTE 2018
  • ADUS 1979
  • Country
  • BLTE United States
  • ADUS United States
  • Employees
  • BLTE N/A
  • ADUS N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • ADUS Medical/Nursing Services
  • Sector
  • BLTE Health Care
  • ADUS Health Care
  • Exchange
  • BLTE Nasdaq
  • ADUS Nasdaq
  • Market Cap
  • BLTE 2.1B
  • ADUS 2.2B
  • IPO Year
  • BLTE 2022
  • ADUS 2009
  • Fundamental
  • Price
  • BLTE $58.91
  • ADUS $132.66
  • Analyst Decision
  • BLTE Strong Buy
  • ADUS Buy
  • Analyst Count
  • BLTE 4
  • ADUS 10
  • Target Price
  • BLTE $96.33
  • ADUS $133.67
  • AVG Volume (30 Days)
  • BLTE 46.8K
  • ADUS 136.7K
  • Earning Date
  • BLTE 03-10-2025
  • ADUS 02-24-2025
  • Dividend Yield
  • BLTE N/A
  • ADUS N/A
  • EPS Growth
  • BLTE N/A
  • ADUS 23.71
  • EPS
  • BLTE N/A
  • ADUS 4.37
  • Revenue
  • BLTE N/A
  • ADUS $1,133,806,000.00
  • Revenue This Year
  • BLTE N/A
  • ADUS $10.52
  • Revenue Next Year
  • BLTE N/A
  • ADUS $24.53
  • P/E Ratio
  • BLTE N/A
  • ADUS $30.36
  • Revenue Growth
  • BLTE N/A
  • ADUS 10.15
  • 52 Week Low
  • BLTE $31.01
  • ADUS $85.94
  • 52 Week High
  • BLTE $86.53
  • ADUS $136.72
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 46.75
  • ADUS 60.20
  • Support Level
  • BLTE $52.03
  • ADUS $124.16
  • Resistance Level
  • BLTE $61.66
  • ADUS $127.00
  • Average True Range (ATR)
  • BLTE 3.51
  • ADUS 2.46
  • MACD
  • BLTE 0.25
  • ADUS 0.79
  • Stochastic Oscillator
  • BLTE 42.55
  • ADUS 68.60

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About ADUS Addus HomeCare Corporation

Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.

Share on Social Networks: